Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
57.6M
-
Shares change
-
+4.34M
-
Total reported value, excl. options
-
$504M
-
Value change
-
+$30.4M
-
Put/Call ratio
-
4.35
-
Number of buys
-
68
-
Number of sells
-
-38
-
Price
-
$8.75
Significant Holders of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) as of Q2 2023
125 filings reported holding TERN - Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.6M shares
of 87.4M outstanding shares and own 65.88% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.62M shares), FMR LLC (7.05M shares), Vivo Capital, LLC (6.66M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.56M shares), BlackRock Inc. (3.14M shares), VR Adviser, LLC (2.97M shares), MILLENNIUM MANAGEMENT LLC (2.28M shares), VANGUARD GROUP INC (2.23M shares), Fairmount Funds Management LLC (2.04M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.9M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.